Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INCY | AMGN | GILD | BIIB | ILMN |
| Company | Incyte Corp | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 52.00 | 272.14 | 67.09 | 193.34 | 120.82 |
| High | 52.22 | 274.48 | 67.68 | 195.86 | 125.70 |
| Low | 51.39 | 271.05 | 67.00 | 192.75 | 120.82 |
| Last | 51.65 | 273.54 | 67.03 | 193.18 | 124.46 |
| Change | -0.27 | +1.63 | +0.08 | -0.93 | +4.21 |
| % Change | -0.52% | +0.60% | +0.12% | -0.48% | +3.50% |
| Volume | 2,493,600 | 2,493,300 | 5,240,200 | 1,461,600 | 1,303,000 |
| 20-Day Average Volume | 1,708,300 | 2,216,505 | 6,335,325 | 1,180,210 | 1,509,115 |
| Previous Close | 51.92 | 271.91 | 66.95 | 194.11 | 120.25 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 54.54 | 271.99 | 69.34 | 202.66 | 127.06 |
| 20-Day Raw Stochastic | 4.22% | 46.12% | 14.18% | 13.30% | 35.87% |
| 20-Day Relative Strength | 28.02% | 48.69% | 32.82% | 31.60% | 45.12% |
| Weighted Alpha | -29.49 | +11.45 | -20.86 | -38.57 | -36.18 |
| Today's Opinion | 100% Sell | 40% Sell | 100% Sell | 100% Sell | 88% Sell |
| Previous Opinion | 100% Sell | 40% Sell | 100% Sell | 100% Sell | 72% Sell |
| Last Month's Opinion | 56% Sell | 8% Buy | 88% Sell | 100% Sell | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.95% since 04/16/24 | +2.97% since 04/16/24 | -0.42% since 04/16/24 | -1.01% since 04/16/24 | +5.75% since 04/16/24 |
| Low | 51.39 on 04/23/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 115.73 on 04/18/24 |
| High | 53.80 on 04/17/24 | 274.48 on 04/23/24 | 67.68 on 04/23/24 | 196.77 on 04/22/24 | 125.70 on 04/23/24 |
| 1-Month | |||||
| %Chg | -9.35% since 03/22/24 | -0.95% since 03/22/24 | -7.68% since 03/22/24 | -11.43% since 03/22/24 | -9.31% since 03/22/24 |
| Low | 51.39 on 04/23/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 115.73 on 04/18/24 |
| High | 57.59 on 03/25/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 218.26 on 03/25/24 | 140.07 on 03/28/24 |
| 3-Month | |||||
| %Chg | -16.52% since 01/23/24 | -11.74% since 01/23/24 | -15.66% since 01/23/24 | -23.24% since 01/23/24 | -11.57% since 01/23/24 |
| Low | 51.39 on 04/23/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 115.73 on 04/18/24 |
| High | 62.14 on 01/24/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 251.99 on 01/31/24 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | -6.26% since 10/23/23 | +0.18% since 10/23/23 | -13.58% since 10/23/23 | -23.76% since 10/23/23 | +4.18% since 10/23/23 |
| Low | 50.27 on 10/31/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 89.00 on 11/10/23 |
| High | 67.36 on 01/04/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,657,390 | 145,845,984 | 83,357,904 | 28,216,022 | 19,150,414 |
| Shares Outstanding, K | 224,526 | 536,376 | 1,245,077 | 145,361 | 159,255 |
| Annual Sales | 3,695,650,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 4,504,000,000 |
| Annual Net Income | 597,600,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | -1,161,000,000 |
| Last Quarter Sales | 1,013,340,000 | 8,196,000,000 | 7,114,000,000 | 2,386,300,000 | 1,122,000,000 |
| Last Quarter Net Income | 201,080,000 | 767,000,000 | 1,429,000,000 | 249,700,000 | -176,000,000 |
| 60-Month Beta | 0.65 | 0.58 | 0.19 | -0.02 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.06 on 02/13/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.95 on 02/13/24 | 0.14 on 02/08/24 |
| Latest Earnings Date | 04/30/24 | 05/02/24 | 04/25/24 | 04/24/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 19.53 | 14.42 | 9.93 | 13.20 | 134.98 |